Cite
HARVARD Citation
Hahm, K. et al. (n.d.). P071 Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect. Journal of Crohn's and colitis. pp. S128-S129. [Online].